Literature DB >> 17662450

Fourth-generation fluoroquinolone-resistant bacterial keratitis.

Vishal Jhanji1, Namrata Sharma, Gita Satpathy, Jeewan Titiyal.   

Abstract

Corneal scrapings were collected from a case of keratitis and microbiological investigations done. Coagulase-negative Staphylococcus (Staphylococcus epidermidis) was identified on culture, and antibiotic susceptibility tests were performed. Treatment was started with topical cefazolin sulfate 5% and gatifloxacin 0.3%; this was subsequently changed to vancomycin 5% and tobramycin sulfate 1.3% based on the sensitivity pattern. The isolates of this bacterium were susceptible to vancomycin, tobramycin, and gentamicin, and resistance was present against moxifloxacin, gatifloxacin, ciprofloxacin, and cefazolin. The case highlights the occurrence of keratitis caused by coagulase-negative Staphylococcus that is resistant to treatment with moxifloxacin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662450     DOI: 10.1016/j.jcrs.2007.04.015

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  13 in total

1.  Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.

Authors:  Merle Fernandes; Divya Vira; Radhika Medikonda; Nagendra Kumar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-04       Impact factor: 3.117

2.  Orlans HO, Hornby SJ, Bowler IC (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye Jan 21 [Epub ahead of print] PMID 21252952.

Authors:  Stephen Kaye; Rose Gilbert; Henri Sueke; Timothy Neal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-29       Impact factor: 3.117

3.  Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment.

Authors:  Abdullah Al-Mujaini; Nadia Al-Kharusi; Archana Thakral; Upender K Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

4.  Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection.

Authors:  Ashok Kumar; Nan Gao; Theodore J Standiford; Richard L Gallo; Fu-Shin X Yu
Journal:  Microbes Infect       Date:  2010-07-01       Impact factor: 2.700

5.  Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

Authors:  Mitchell H Friedlaender; Eugene Protzko
Journal:  Clin Ophthalmol       Date:  2008-03

6.  Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-18       Impact factor: 3.117

7.  Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.

Authors:  Thomas W Carion; Matthew Greenwood; Abdul Shukkur Ebrahim; Andrew Jerome; Susmit Suvas; Karsten Gronert; Elizabeth A Berger
Journal:  FASEB J       Date:  2018-04-13       Impact factor: 5.191

8.  Diversity of microbial species implicated in keratitis: a review.

Authors:  Elisabeth Karsten; Stephanie Lousie Watson; Leslie John Ray Foster
Journal:  Open Ophthalmol J       Date:  2012-11-30

Review 9.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

10.  Spectrum of bacterial keratitis at a tertiary eye care centre in India.

Authors:  Jayaraman Kaliamurthy; Catti Muniswamy Kalavathy; Pragya Parmar; Christadas Arul Nelson Jesudasan; Philip A Thomas
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.